ncRNAs: Diverse Roles, Disease, Diagnostics, Therapy

Jakob H. Nielsen^*
*Correspondence: Jakob H. Nielsen, Department of Population Genetics, Nordic Institute of Bioinformatics, Copenhagen, Denmark, Email:

Introduction

Non-coding RNAs (ncRNAs), particularly MicroRNAs (miRNAs) and Long Non-coding RNAs (lncRNAs), play critical roles in the development and progression of renal cell carcinoma. They influence various cellular processes like proliferation, apoptosis, and metastasis, acting as oncogenes or tumor suppressors. Understanding these roles offers promising avenues for novel diagnostic biomarkers and targeted therapeutic strategies for kidney cancer [1].

Circular RNAs (circRNAs) are a distinct class of ncRNAs, formed by back-splicing, with increasing recognition for their diverse functions in cellular regulation and disease, especially cancer. They act as miRNA sponges, regulate gene expression, and interact with proteins, significantly influencing tumorigenesis, progression, and metastasis. Understanding circRNA biology offers new insights for cancer diagnosis and therapy [2].

Long non-coding RNAs (lncRNAs) are emerging as crucial regulators in the pathogenesis of various neurodegenerative diseases, including Alzheimer's and Parkinson's. They influence gene expression through epigenetic, transcriptional, and post-transcriptional mechanisms, affecting neuronal survival, inflammation, and amyloid pathology. Unraveling lncRNA functions could lead to novel diagnostic and therapeutic strategies for these debilitating conditions [3].

MicroRNAs (miRNAs) represent a significant frontier in molecular medicine, offering potential as both diagnostic biomarkers and therapeutic targets across a spectrum of diseases. Their precise regulatory roles in gene expression make them attractive candidates for developing advanced therapies, including miRNA mimics and anti-miRs, for conditions ranging from cancer to cardiovascular disorders [4].

Piwi-interacting RNAs (piRNAs), known for their role in germline integrity and transposon silencing, are increasingly being implicated in somatic cell functions and various diseases, including cancer and neurological disorders. Their complex regulatory mechanisms, often involving epigenetic modifications, suggest they hold significant potential as novel biomarkers and therapeutic targets beyond reproductive health [5].

Non-coding RNAs are pivotal players in the intricate network of immune regulation, influencing both innate and adaptive immune responses. They modulate the differentiation, activation, and function of immune cells, impacting the development and progression of autoimmune diseases, infections, and cancers. This deep involvement makes them promising targets for immune-modulating therapies [6].

Exosomal non-coding RNAs, encapsulated within exosomes, act as crucial mediators of intercellular communication and are recognized for their stability and presence in biofluids. This makes them exceptionally promising as non-invasive diagnostic biomarkers for various human diseases, including cancer and neurological disorders, and as delivery vehicles for targeted therapies [7].

Long non-coding RNAs (lncRNAs) are increasingly recognized for their critical involvement in regulating metabolic processes and contributing to metabolic diseases like diabetes, obesity, and fatty liver disease. They exert control over gene expression by various mechanisms, influencing glucose homeostasis, lipid metabolism, and energy balance, highlighting their potential as therapeutic targets [8].

Non-coding RNAs play sophisticated roles in antiviral immunity, acting as both host defense mechanisms and targets exploited by viruses. They modulate the host immune response by regulating gene expression, interfering with viral replication, and shaping the inflammatory landscape. Understanding these interactions is crucial for developing new antiviral therapies and vaccines [9].

Non-coding RNAs are emerging as key regulators in regenerative medicine, influencing stem cell self-renewal, differentiation, and tissue repair. Their ability to finely tune gene expression makes them powerful tools for enhancing therapeutic outcomes in tissue engineering, wound healing, and treating degenerative diseases, offering new strategies for restoring function [10].

Description

Non-coding RNAs (ncRNAs) represent a diverse class of molecules significantly impacting cellular processes and disease pathogenesis. These include MicroRNAs (miRNAs), Long Non-coding RNAs (lncRNAs), Circular RNAs (circRNAs), Piwi-interacting RNAs (piRNAs), and Exosomal ncRNAs [1, 2, 3, 4, 5, 7]. Their fundamental role lies in precisely modulating gene expression through epigenetic, transcriptional, and post-transcriptional mechanisms. This intricate control allows ncRNAs to influence a wide array of biological functions, from basic cell survival to complex systemic regulations [3, 8]. The deep involvement of ncRNAs in these regulatory networks underscores their profound impact on maintaining cellular homeostasis and responding to various pathological conditions.

In the context of disease, ncRNAs are deeply implicated across multiple fronts. For instance, in renal cell carcinoma, miRNAs and lncRNAs act as critical regulators, either promoting or suppressing tumor progression by affecting processes like proliferation, apoptosis, and metastasis, thereby shaping the disease trajectory [1]. Similarly, Circular RNAs (circRNAs) are recognized for their substantial influence on tumorigenesis, progression, and metastasis in various cancers, often by acting as miRNA sponges or interacting directly with proteins [2]. Beyond oncology, lncRNAs are emerging as crucial factors in neurodegenerative diseases, including Alzheimer's and Parkinson's. Here, they modulate neuronal survival, inflammation, and amyloid pathology. Understanding these contributions offers innovative pathways for developing novel diagnostic and therapeutic strategies for these conditions [3].

The regulatory reach of ncRNAs extends significantly into the immune system and metabolic processes. Non-coding RNAs are pivotal players in the intricate network of immune regulation, influencing both innate and adaptive immune responses. They precisely modulate immune cell differentiation, activation, and function, directly impacting autoimmune diseases, infections, and cancers [6]. This broad involvement positions ncRNAs as promising targets for developing novel immune-modulating therapies. Furthermore, Long Non-coding RNAs (lncRNAs) are increasingly recognized for their critical involvement in metabolic regulation, contributing to prevalent metabolic diseases like diabetes, obesity, and fatty liver disease. Their control over gene expression impacts glucose homeostasis, lipid metabolism, and energy balance, highlighting their potential as significant therapeutic targets [8].

The unique characteristics of ncRNAs make them exceptionally promising tools in molecular medicine, for both diagnosis and treatment. MicroRNAs (miRNAs), for example, offer significant potential as diagnostic biomarkers and therapeutic targets across a wide spectrum of human diseases, from cancer to cardiovascular disorders. This is achieved through advanced therapeutic strategies involving miRNA mimics and anti-miRs [4]. Piwi-interacting RNAs (piRNAs), initially known for germline integrity, are now implicated in somatic cell functions and various diseases, including cancer and neurological disorders. Their complex regulatory mechanisms suggest they hold significant potential as novel biomarkers and therapeutic targets beyond reproductive health [5]. Moreover, Exosomal non-coding RNAs, due to their remarkable stability and detectable presence in biofluids, are exceptionally promising as non-invasive diagnostic biomarkers for conditions like cancer and neurological disorders. They also show great promise as natural delivery vehicles for targeted therapies [7].

Finally, ncRNAs demonstrate sophisticated roles in antiviral immunity, acting both as crucial host defense mechanisms and as targets cleverly exploited by viruses. They modulate the host immune response by regulating gene expression, interfering with viral replication, and shaping the inflammatory landscape. Understanding these complex interactions is crucial for developing new antiviral therapies and effective vaccines [9]. In the realm of regenerative medicine, ncRNAs are emerging as key regulators, profoundly influencing stem cell self-renewal, differentiation, and tissue repair processes. Their ability to finely tune gene expression makes them powerful tools for enhancing therapeutic outcomes in tissue engineering, accelerating wound healing, and treating degenerative diseases. This opens new and innovative strategies for functional restoration [10].

Conclusion

Non-coding RNAs (ncRNAs), encompassing MicroRNAs (miRNAs), Long Non-coding RNAs (lncRNAs), Circular RNAs (circRNAs), Piwi-interacting RNAs (piRNAs), and Exosomal ncRNAs, represent a significant and diverse class of molecules with critical roles in biological processes and disease pathogenesis. These ncRNAs are deeply involved in the development and progression of various cancers, such as renal cell carcinoma, where they act as oncogenes or tumor suppressors, influencing cellular processes like proliferation, apoptosis, and metastasis. Beyond cancer, lncRNAs are recognized as crucial regulators in neurodegenerative conditions like Alzheimer's and Parkinson's, affecting neuronal survival and inflammation through epigenetic mechanisms. They also contribute to metabolic diseases, including diabetes and obesity, by regulating gene expression and influencing glucose and lipid metabolism. The functions of other ncRNA types extend to immune regulation, where they modulate innate and adaptive immune responses, making them promising targets for immune-modulating therapies. Furthermore, ncRNAs play sophisticated roles in antiviral immunity, acting as both host defense mechanisms and viral targets. Their potential as diagnostic biomarkers is highlighted by the stability and presence of exosomal ncRNAs in biofluids, offering non-invasive detection for various human diseases. In regenerative medicine, ncRNAs are key regulators, impacting stem cell self-renewal and tissue repair. This extensive involvement across numerous physiological and pathological states positions ncRNAs as promising avenues for developing novel diagnostic tools and targeted therapeutic strategies for a wide spectrum of human conditions.

Acknowledgement

None

Conflict of Interest

None

References

Xuemin C, Jianming G, Hongda H. "Non-coding RNAs as Regulators and Therapeutic Targets in Renal Cell Carcinoma".Front Pharmacol 14 (2023):1184988.

Indexed at, Google Scholar, Crossref

Junwei T, Fan Y, Jing W. "Circular RNAs: Biogenesis, functions, and roles in cancer".Cell Death Dis 13 (2022):885.

Indexed at, Google Scholar, Crossref

Meihua L, Jianling F, Xiangmei L. "Long non-coding RNAs: New insights into neurodegenerative diseases".Front Neurosci 15 (2021):651666.

Indexed at, Google Scholar, Crossref

Pranjali G, Anuj K, Rajan S. "MicroRNAs: A new horizon for disease diagnosis and therapy".Front Pharmacol 15 (2024):1357677.

Indexed at, Google Scholar, Crossref

Xuelian W, Yuanyuan F, Xiaolin Z. "Piwi-interacting RNAs (piRNAs) and their roles in various diseases".Aging Cell 22 (2023):e13759.

Indexed at, Google Scholar, Crossref

Jinhu Y, Bingyi X, Zhen L. "Non-coding RNAs in immune regulation and diseases".Cell Biosci 12 (2022):102.

Indexed at, Google Scholar, Crossref

Mengqi Z, Yu L, Hongwei W. "Exosomal non-coding RNAs: Potential biomarkers and Therapeutic Targets for Human Diseases".Front Cell Dev Biol 11 (2023):1210870.

Indexed at, Google Scholar, Crossref

Xinxin Y, Jin S, Jing B. "The Emerging Role of Long Non-Coding RNAs in Metabolic Regulation and Disease".Int J Mol Sci 22 (2021):7183.

Indexed at, Google Scholar, Crossref

Yan-Ming H, Ming-Xin C, Guo-Qiang M. "Non-coding RNAs in antiviral immunity".J Med Virol 92 (2020):955-966.

Indexed at, Google Scholar, Crossref

Mingjia Z, Yuchen Y, Yanan H. "Non-coding RNAs in Regenerative Medicine".Int J Mol Sci 20 (2019):2577.

Indexed at, Google Scholar, Crossref